Amyris Sued For Cannabis Trade Secrets

Biotechnology company Amyris, Inc. (Nasdaq: AMRS) is being sued by biosynthetic cannabinoid company LAVVAN, Inc. for $881 million. The lawsuit is related to Amyris’s use of intellectual property licensed exclusively […]